How We Achieved 5.4× ROAS on a Peptide Brand With Zero Account Flags

Case StudyMeta Ads8 min read

When a UK-based BPC-157 brand approached us, they'd just lost their third Meta advertising account in 18 months. Their previous agency had been using direct health claims in ad copy — specifically referencing tissue repair and joint recovery — which violated Meta's medical and health claims policies.

The Problem

The brand was spending £12K/month with a 2.1× ROAS before each account suspension. The cycle was destroying their business: 6-8 weeks of profitable scaling, then an account ban, then 3-4 weeks of rebuilding, then another ban.

Our Approach

We started with a full compliance audit before placing a single ad. We mapped every claim their previous agency had used against Meta's current health and medical products policy, identifying 23 specific violations across their ad copy library.

The rebuild focused on three principles: structural claims over health claims, brand values over product benefits, and social proof over direct assertions.

The Creative Framework

Instead of "BPC-157 for faster joint recovery," we built creative around: the brand's research standards, quality control processes, and the community of performance-focused customers who trust the product. The ads never referenced specific health outcomes.

The Results

Over the following 90 days: 5.4× blended ROAS, £18.40 average CPA, zero ad disapprovals, zero account flags. The brand scaled from £0 to £22K/month in managed spend.

The key insight: compliance isn't the enemy of performance — it's the foundation of sustainable performance.

The Complete Guide to Compliant Peptide Advertising on Meta in 2026

Policy Guide12 min read

Meta's advertising policies around health and medical claims have undergone significant changes since 2023. For peptide brands, the compliance landscape is now more complex than ever — but it's entirely navigable with the right framework.

What Triggers Review

Meta's automated systems flag ads that contain: direct references to specific peptide compound names in conjunction with health outcomes, before/after claims, treatment language, and anything that implies the product cures, treats, or prevents a medical condition.

The Permitted Framework

You can advertise around: the quality and purity of your product, your manufacturing standards, the general category of performance supplements, your brand story and values, and social proof from customers (carefully worded).

The 27-Rule Compliance Checklist

We've distilled five years of compliance work into a 27-rule checklist. The core rules: never use the word "treatment" or "cure," never reference specific medical conditions, never make comparative health claims, always use "research purposes" language where applicable, and always run copy through Meta's Ad Policy tool before launching.

Creative Formats That Perform

Video creative with founders discussing their brand values consistently outperforms product-focused creative in compliance-sensitive categories. Educational content framed around the research landscape (not health claims) is also highly effective.

Server-Side CAPI: Why Your Peptide Brand Is Reporting 40% Less Revenue Than It Actually Makes

TechnicalAttribution10 min read

If you're running Meta ads for a peptide brand and your dashboard ROAS looks disappointing, there's a strong chance your tracking is missing a significant portion of your actual conversions. We've seen this across every client we've audited.

The iOS 14 Problem, Still

Apple's App Tracking Transparency (ATT) framework, introduced in iOS 14.5, broke browser-based pixel tracking. When a user who has opted out of tracking clicks your ad and purchases, Meta's pixel never fires — because the pixel is blocked by the browser before it can report back.

The Scale of the Problem

Across the peptide brand accounts we've audited, we consistently find that browser-pixel-only tracking underreports conversions by 35-45%. That means if your dashboard shows a 2.8× ROAS, your actual ROAS is likely 4.2× or higher.

Server-Side CAPI Explained

Meta's Conversions API (CAPI) works differently from the browser pixel. Instead of a JavaScript tag firing in the user's browser (which can be blocked), CAPI sends conversion data directly from your server to Meta's servers. iOS privacy settings don't apply to server-to-server communication.

Implementation

Proper CAPI implementation requires: a server-side event endpoint, event deduplication between browser and server events, and advanced matching using hashed customer data (email, phone) to improve match rates. When implemented correctly, we consistently achieve 94-97% match rates.

BPC-157 Marketing: What You Can and Cannot Say on Ad Platforms

Compliance Guide9 min read

BPC-157 (Body Protection Compound 157) is a synthetic peptide derived from a protein found in human gastric juice. It's one of the most researched peptides in the sports performance and recovery category — and one of the most aggressively reviewed by Meta and Google's ad policy teams.

Why BPC-157 Is High-Risk on Platforms

The compound is frequently associated with recovery, healing, and tissue repair in the research literature. These associations make any copy referencing the compound vulnerable to policy flags — even if you're not making explicit health claims. The platform's AI systems pattern-match on compound names combined with adjacent health vocabulary.

What You Cannot Say

Any reference to joint, tendon, or ligament recovery
Any reference to gut health, inflammation, or healing
Comparative claims vs. other supplements or medications
Testimonials referencing health outcomes
Any "before/after" framing

What You Can Say

Quality and purity standards of your manufacturing process
Third-party testing and certificate of analysis references
Brand story, founder motivation, research standards
"Research grade" or "for research purposes only" framing
General performance supplement positioning

The Creative Strategy

Our most successful BPC-157 campaigns never mention the compound in ad copy at all. The landing page carries that information. The ads focus on the brand's credibility, testing standards, and the community of serious users who trust the product.

Peptide Email Marketing: Building a 35% Revenue Channel From Scratch

StrategyEmail Marketing8 min read

Email is the one channel that platforms can't take away from you. For peptide brands that live under the constant threat of ad account suspension, a strong email list is existential insurance — and a significant revenue driver in its own right.

The List Architecture

We segment peptide email lists into four core audiences: new subscribers (cold, education phase), one-time purchasers (conversion to second order), repeat purchasers (loyalty and upsell), and lapsed customers (win-back sequences). Each segment gets different messaging with different compliance requirements.

The Welcome Series

The most valuable email sequence for a peptide brand is the welcome series. Days 1-7 focus on brand education, quality standards, and research context. Days 8-21 introduce the product range with social proof. Days 22-30 make the first purchase offer with a specific incentive.

Compliance in Email

Email is more permissive than paid advertising — you're communicating with people who have opted in to hear from you. But MHRA guidelines and ASA CAP codes still apply. The same principles hold: structural and quality claims, not health claims.

The Revenue Numbers

On average, a well-executed email programme for a peptide brand with a list of 5,000+ subscribers generates 25-35% of total revenue. The cost per acquisition from email is near-zero after the initial list build, making it the highest-margin channel in the stack.

Google Ads for Peptide Brands: The Keyword Strategy That Actually Works

StrategyGoogle Ads9 min read

Google Ads for peptide brands is significantly different from standard e-commerce advertising. The keyword landscape contains minefield terms that trigger policy flags, and the intent signals are more complex than a simple "buy X" search.

The Keyword Framework

We organise peptide Google Ads campaigns into three tiers: Research Intent (high volume, low commercial intent, educational), Comparison Intent (mid-funnel, actively researching purchase), and Purchase Intent (high commercial intent, ready to buy).

Compliant Keyword Targeting

Generic terms like "research peptides" and "peptide supplier UK" are substantially safer than compound-specific terms paired with indication language. We build the majority of budget around branded and category terms, using compound-specific terms only on landing pages (not in ad copy).

Shopping Campaigns

Google Shopping is often overlooked by peptide brands. Product listing ads (PLAs) carry less copy scrutiny than text ads, and the visual format performs well for premium positioned products. The key is the product title — "Research Grade BPC-157 — 5mg — Certificate of Analysis Included" outperforms generic titles significantly.

The Bidding Strategy

We use Target ROAS bidding for campaigns with sufficient conversion data (minimum 30 conversions in 30 days). Below this threshold, manual CPC with bid adjustments for device, location, and time of day consistently outperforms automated strategies.

Why Biohacking Audiences Convert Differently — And How to Market to Them

StrategyAudience Research7 min read

The biohacking market is unlike any other segment in the supplement space. These are not impulse buyers. They are educated, research-led individuals who have already read the PubMed papers on the compounds they're interested in — and they'll see through any marketing that overpromises or underdelivers on substance.

The Biohacker Mindset

Biohackers approach supplementation scientifically. They want to understand mechanisms, read study citations, and understand quality differentiation. The marketing that resonates is educational, precise, and treats the customer as intelligent.

Creative That Works

Long-form video content explaining research mechanisms significantly outperforms short-form product ads for biohacking audiences. Podcast advertising (organic and paid) is extremely effective. Email newsletters with substantive research summaries generate exceptional engagement.

The Trust Signals That Matter

Third-party certificates of analysis, manufacturing standards (ISO, GMP), founder credentials, and research affiliations all perform well in biohacking creative. Brand transparency about sourcing and testing protocols is particularly valuable.

Acquisition Cost Dynamics

Biohacking audience CPMs are higher than generic supplement audiences. However, the lifetime value is significantly greater — average order values are 40-60% higher, and repeat purchase rates are exceptional. The economics work well when lifetime value is properly factored in.

Peptide Landing Page Anatomy: The 7-Element Formula for Sub-2% Bounce Rate

CROLanding Pages8 min read

The average bounce rate for a peptide brand landing page receiving paid traffic is 55-65%. That means more than half your ad spend is wasted before the page even has a chance to convert. We've spent years refining the landing page structure that keeps visitors engaged and moving toward purchase.

Element 1: The Compliance-Safe Hero

The above-the-fold section must immediately signal brand credibility without making restricted claims. We use a hero that communicates three things: who the product is for, the quality standard, and one compelling social proof element. No health claims.

Element 2: The Trust Bar

Immediately below the hero: certificate of analysis badge, manufacturing standard, and a quantity indicator ("Trusted by 8,000+ performance athletes"). This social proof section handles the scepticism before the visitor reads a word of body copy.

Element 3: The Product Specifics

Research-grade buyers want technical detail. Molecular weight, purity percentage, storage specifications, and reconstitution notes. This section separates premium brands from generic suppliers and justifies the price point.

Element 4: The Research Section

A brief research context section citing available studies (without making specific health claims) satisfies the biohacking audience's need for scientific credibility. "As studied in published research for [general area]" framing works within compliance guidelines.

Elements 5-7: Social Proof, FAQ, and CTA

Verified customer reviews (carefully moderated for compliance), an FAQ answering the top objections (purity, shipping, storage, returns), and a clear, simple checkout CTA. No forced upsells at the landing page stage — those come in the post-purchase sequence.

Attribution in a Post-iOS-14 World: How Peptide Brands Can Trust Their Data Again

TechnicalAttribution11 min read

Three years after iOS 14.5 and the App Tracking Transparency framework changed digital advertising forever, many peptide brands are still running their campaigns on fundamentally broken attribution data. Here's how to fix it.

The Three Layers of Modern Attribution

Accurate attribution in 2026 requires three complementary data sources: server-side CAPI events (for real-time platform reporting), first-party analytics (GA4 with enhanced measurement), and post-purchase survey data (for channel attribution beyond what platforms can see).

CAPI Implementation

Meta's Conversions API, properly implemented with your Shopify or WooCommerce backend, can recover 35-45% of the conversions that browser pixels miss. The critical technical requirements: server-side event deduplication, advanced matching with hashed customer PII, and proper event priority ordering.

GA4 Configuration

GA4's server-side Google Tag Manager setup, combined with user ID tracking for logged-in customers, gives you a parallel data source that isn't subject to the same privacy restrictions as Meta's pixel. Configuring custom events for key funnel steps gives you attribution data that platforms can't provide.

The Reconciliation Process

We run a monthly attribution reconciliation for every client: platform-reported revenue vs. GA4-reported revenue vs. actual backend orders. The gaps tell you where tracking is still broken and where to invest in fixes.

The ROI of Attribution

One client discovered that their highest-ROAS campaign (on paper) was actually their lowest-performing campaign when server-side data was reconciled. They'd been scaling the wrong channel for six months. Proper attribution pays for itself in the first month.

From £0 to £650K in Managed Ad Spend: Lessons From Building a Specialist Agency

Agency Insights6 min read

Building a specialist agency in a compliance-sensitive niche is fundamentally different from building a generalist digital marketing agency. The learning curve is steeper, the mistakes are more costly, and the relationship between performance and compliance is unlike anything we'd encountered in mainstream e-commerce.

Why Specialism Works

Generalist agencies lose peptide client accounts for the same reason, every time: they don't know what they don't know. They apply the same creative frameworks that work for fashion or electronics, and they get flagged immediately. Specialism means you've already mapped every edge case before a client ever asks.

The Compliance Architecture

The single most important investment we made early was building a comprehensive compliance framework before we signed the first client. This included: a complete mapping of Meta and Google policies against every type of peptide claim, a pre-launch review process for all creative assets, and a tracking setup template built around server-side CAPI from day one.

What We'd Do Differently

We'd invest in client education earlier. The most common source of account risk isn't our work — it's organic posts, website copy, or third-party marketplaces that contradict the compliance framework we've built. Teaching clients to think about their entire digital footprint, not just the ads we run, is now part of every onboarding.

The Current State

£650K+ in safely managed ad spend. 14+ brands scaled to profitability. 99.8% ad approval rate. Zero client account suspensions in the last 18 months. The specialist approach works — not just for performance, but for the sustainability of every brand we serve.

Peptide CRO: The 5 Conversion Fixes That Delivered 68% More Revenue

CROCase Study7 min read

A peptide DTC brand with good product-market fit and solid paid traffic was converting at 1.8% on their landing page. We ran a full CRO audit and identified five specific problems. After fixing them over a 45-day period, conversion rate reached 4.1% — a 68% revenue lift at identical ad spend.

Fix 1: Page Speed

The existing landing page loaded in 4.2 seconds on mobile. Every second of load time above 2 seconds costs approximately 7% of conversions. We rebuilt the page with optimised image formats, deferred JavaScript, and a CDN. Result: 1.8-second mobile load time.

Fix 2: Compliance-Safe Hero Rewrite

The original hero made three borderline health claims that made the page feel legally uncertain to informed buyers. We rewrote around quality claims and social proof. Bounce rate from the hero section dropped by 22%.

Fix 3: Trust Signals Architecture

Certificate of analysis and third-party testing were buried at the bottom of the page. Moving these to immediately below the hero (the "trust bar") increased scroll depth by 34% — meaning more visitors reached the product and pricing sections.

Fix 4: Mobile Checkout Flow

67% of paid traffic was mobile, but the checkout flow had seven steps optimised for desktop. We reduced to four steps with mobile-first form fields. Mobile conversion rate increased by 41%.

Fix 5: Cart Abandonment Trigger

There was no exit-intent mechanism. We added a subtle offer trigger at 60-second page engagement for visitors who showed scroll intent but hadn't added to cart. Conversion rate on this segment: 6.2%.

The Compliance Playbook: 27 Rules Every Peptide Brand Must Follow on Meta

ComplianceReference Guide14 min read

After three years of running compliant peptide advertising across Meta platforms, we've compiled every rule, guideline, and policy interpretation into a single reference document. This is the playbook we use for every new client onboarding.

Account-Level Rules (1-8)

Rule 1: Never use personal health information in targeting parameters
Rule 2: Business page must not reference specific health conditions
Rule 3: Domain must be verified before running any health-adjacent creative
Rule 4: Store policy page must be live and accessible before campaign launch
Rule 5: Terms of service and disclaimer must be visible on all landing pages
Rule 6: "For research purposes only" language must appear on product pages
Rule 7: No automatic retargeting of users who have engaged with restricted health content
Rule 8: Account spending history matters — new accounts are scrutinised more heavily

Creative Rules (9-18)

Rule 9: Never use words: cure, treat, heal, repair, fix in relation to the body
Rule 10: No before/after imagery or copy
Rule 11: No imagery of medical professionals or clinical settings
Rule 12: No direct naming of medical conditions
Rule 13: Testimonials must not reference health outcomes
Rule 14: Social proof must be about the brand/product quality, not health effects
Rule 15: Video creative must not show product being injected or administered
Rule 16: No "scientifically proven" language without FCA/MHRA approved study citations
Rule 17: Avoid compound names paired with indication language in ad copy
Rule 18: Landing page destination must match ad messaging (no bait-and-switch)

Landing Page Rules (19-27)

Rule 19: Page must load in under 3 seconds (non-negotiable for approval)
Rule 20: Contact information must be visible and functional
Rule 21: Return policy must be clearly stated
Rule 22: Age gate or verification where required by jurisdiction
Rule 23: No pop-ups that block page content before user interaction
Rule 24: Pricing must be clear with no hidden fees
Rule 25: No automatic subscription enrolment without explicit consent
Rule 26: GDPR-compliant cookie consent mechanism required for EU traffic
Rule 27: Checkout SSL certificate must be valid and visible

Insights From The Frontline Of Peptide Performance Marketing.